Fig. 4.
Transcriptomic evaluation by real-time quantitative polymerase chain reaction of (A) hypoxic preconditioning markers, (B) apoptosis and mobility cellular markers, (C) endothelial activation markers, and (D) innate immunity markers. Results are expressed as mean ± SEM in relative folds change to healthy kidney. EPO = erythropoïetin; HIF1α = hypoxia-inducible factor-1α; HO1 = heme oxygenase-1; IFNγ = interferon-γ; IL = interleukin; MCP-1 = monocyte chemoattractant protein-1; TLR = toll-like receptor; TLV = total liquid ventilation; TNFα = tumor necrosis factor-α; VCAM1 = vascular cell adhesion molecule; VEGF = vascular endothelial growth factor.

Transcriptomic evaluation by real-time quantitative polymerase chain reaction of (A) hypoxic preconditioning markers, (B) apoptosis and mobility cellular markers, (C) endothelial activation markers, and (D) innate immunity markers. Results are expressed as mean ± SEM in relative folds change to healthy kidney. EPO = erythropoïetin; HIF1α = hypoxia-inducible factor-1α; HO1 = heme oxygenase-1; IFNγ = interferon-γ; IL = interleukin; MCP-1 = monocyte chemoattractant protein-1; TLR = toll-like receptor; TLV = total liquid ventilation; TNFα = tumor necrosis factor-α; VCAM1 = vascular cell adhesion molecule; VEGF = vascular endothelial growth factor.

Close Modal

or Create an Account

Close Modal
Close Modal